Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: TFF PHARMACEUTICALS, INC.
CIK: 1733413
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2019-12-09
Last Filing Date: 2024-11-20
SEC Filings
Start End Frame Filed ACCN Value View
2020-07-01 2020-09-30 CY2020Q3 2021-11-15 0001213900-21-059329 $ 400,000 View
2019-01-01 2019-09-30 CY2018Q3 2019-12-09 0001213900-19-025650 $ 400,000 View
2019-01-01 2019-12-31 CY2019 2020-03-27 0001213900-20-007544 $ 400,000 View
2020-01-01 2020-03-31 CY2019Q1 2020-05-14 0001213900-20-012260 $ 400,000 View
2020-01-01 2020-06-30 CY2019Q2 2020-08-13 0001213900-20-021865 $ 400,000 View
2020-01-01 2020-03-31 CY2020Q1 2021-05-13 0001213900-21-026067 $ 400,000 View
2020-01-01 2020-09-30 CY2019Q3 2020-11-05 0001213900-20-035277 $ 400,000 View
2020-01-01 2020-12-31 CY2020 2021-03-10 0001213900-21-014575 $ 400,000 View
2021-04-01 2021-06-30 CY2021Q2 2021-08-12 0001213900-21-042002 $ 400,000 View
2021-01-01 2021-12-31 CY2020Q4I 2022-03-24 0001213900-22-014844 $ 416,910 View
2022-01-01 2022-03-31 CY2021Q1 2022-05-11 0001213900-22-025580 $ 25,371,781 View
2022-04-01 2022-06-30 CY2022Q2 2022-08-11 0001213900-22-046849 $ 25,373,706 View
2022-07-01 2022-09-30 CY2022Q3I 2022-11-14 0001213900-22-072188 $ 76,000 View
2022-01-01 2022-12-31 CY2022 2023-03-31 0001213900-23-025454 $ 1,812,975 View
2023-01-01 2023-03-31 CY2023Q1 2023-05-11 0001213900-23-038530 $ 4,018,659 View
2023-04-01 2023-06-30 CY2023Q2 2023-08-14 0001213900-23-067041 $ -7,566 View
2023-01-01 2022-12-31 CY2022Q4I 2023-11-14 0001213900-23-086896 $ 138,000 View
2023-01-01 2023-08-31 CY2023Q3I 2024-03-28 0001213900-24-027185 $ 7 View
2024-01-01 2024-03-31 CY2024Q1I 2024-05-14 0001213900-24-042918 $ 7,688 View
2024-04-01 2024-04-30 CY2024Q1I 2024-08-14 0001213900-24-068964 $ 123,356 View
2024-07-01 2024-09-30 CY2024Q3 2024-11-20 0001213900-24-100587 $ 87,000 View
SEC Facts By Type
Type Name Description View
us-gaap Sale of Stock, Number of Shares Issued in Transaction The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. View
us-gaap Sale of Stock, Price Per Share Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Other Liabilities, Current Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. View
us-gaap Other Preferred Stock Dividends and Adjustments Amount of preferred stock dividends and adjustments classified as other. View
us-gaap Other Research and Development Expense Amount of other research and development expense. View
us-gaap Payments of Stock Issuance Costs The cash outflow for cost incurred directly with the issuance of an equity security. View
us-gaap Sale of Stock, Consideration Received on Transaction Cash received on stock transaction after deduction of issuance costs. View
us-gaap Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed Percentage of principal amount of debt redeemed. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
us-gaap Other Accrued Liabilities, Noncurrent Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accounts Payable Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Accrued Liabilities Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
us-gaap Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Other Comprehensive Income (Loss), Tax Amount of tax expense (benefit) allocated to other comprehensive income (loss). View
us-gaap Other Income Amount of revenue and income classified as other. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Debt Instrument, Convertible, Beneficial Conversion Feature Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date. View
us-gaap Debt Instrument, Convertible, Conversion Price The price per share of the conversion feature embedded in the debt instrument. View
us-gaap Debt Instrument, Fee Amount Amount of the fee that accompanies borrowing money under the debt instrument. View
us-gaap Deferred Federal Income Tax Expense (Benefit) Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Deferred Foreign Income Tax Expense (Benefit) Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Deferred Offering Costs Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. View
us-gaap Deferred Tax Assets, Goodwill and Intangible Assets Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, in Process Research and Development Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards, Research Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. View
us-gaap Dividends Payable, Current Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Dividends, Preferred Stock, Stock Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock. View
us-gaap Due from Related Parties For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense. View
us-gaap Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Amount of cost to be recognized for option under share-based payment arrangement. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Interest Income (Expense), Net The net amount of operating interest income (expense). View
us-gaap Operating Leases, Rent Expense Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Manufacturing Costs The aggregate costs incurred in the production of goods for sale. View
us-gaap Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest. View
us-gaap Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. View
us-gaap Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Operating Lease, Cost Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability. View
us-gaap Operating Leases, Future Minimum Payments Due Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year. View
us-gaap Operating Leases, Future Minimum Payments Due, Next Twelve Months Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Due in Two Years Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Preconfirmation, Cash and Cash Equivalents Amount of cash and cash equivalents at the balance sheet date before fresh-start adjustments. View
us-gaap Preferred Stock, Dividend Rate, Percentage The percentage rate used to calculate dividend payments on preferred stock. View
us-gaap Preferred Stock Dividends, Income Statement Impact The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Prepaid Expense and Other Assets Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. View
us-gaap Proceeds from Issuance of Private Placement The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. View
us-gaap Proceeds from Issuance of Warrants The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Research and Development Expense (Excluding Acquired in Process Cost) The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. View
us-gaap Research and Development in Process The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. View
us-gaap Restricted Cash Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate The risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Net number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price Change in the weighted average exercise price of options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average price at which option holders acquired shares when converting their stock options into shares. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Share Price Price of a single share of a number of saleable stocks of a company. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stock Issued During Period, Shares, New Issues Number of new stock issued during the period. View
us-gaap Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Other Value of shares of stock issued attributable to transactions classified as other. View
us-gaap Temporary Equity, Liquidation Preference The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Increase (Decrease) in Accrued Salaries The increase (decrease) during the period in accrued salaries. View
us-gaap Capital Expenditures Incurred but Not yet Paid Future cash outflow to pay for purchases of fixed assets that have occurred. View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Other Expenses Amount of expense classified as other. View
us-gaap Other General and Administrative Expense Amount of general and administrative expense classified as other. View
us-gaap Other Receivables Amount due from parties in nontrade transactions, classified as other. View
us-gaap Percentage of Weighted Average Cost Inventory The percentage of weighted average cost inventory present at the reporting date when inventory is valued using different valuation methods. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap 371440 None View
us-gaap Lease, Cost Amount of lease cost recognized by lessee for lease contract. View
us-gaap Lessee, Operating Lease, Liability, to be Paid Amount of lessee's undiscounted obligation for lease payment for operating lease. View
us-gaap Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs Amount of deferred tax liability attributable to taxable temporary differences from research and development costs. View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year Four Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year Three Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year Two Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Long-term Debt and Lease Obligation, Current Amount of long-term debt and lease obligation, classified as current. View
us-gaap Operating Lease, Lease Income, Lease Payments Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable. View
us-gaap Operating Lease, Liability Present value of lessee's discounted obligation for lease payments from operating lease. View
us-gaap Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. View
us-gaap Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. View
us-gaap Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease. View
us-gaap Operating Lease, Right-of-Use Asset, Amortization Expense Amount of amortization expense for right-of-use asset from operating lease. View
us-gaap Operating Lease, Weighted Average Discount Rate, Percent Weighted average discount rate for operating lease calculated at point in time. View
us-gaap Other Assets, Noncurrent Amount of noncurrent assets classified as other. View
us-gaap Payment of Financing and Stock Issuance Costs The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities. View
us-gaap Receivable with Imputed Interest, Net Amount The receivable or note face amount less the unamortized discount or premium. View
us-gaap Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation. View
us-gaap Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Amount of increase in right-of-use asset obtained in exchange for operating lease liability. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. View
us-gaap Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options. View
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. View
us-gaap Derivative, Gain (Loss) on Derivative, Net Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. View
us-gaap Increase (Decrease) in Prepaid Expenses, Other Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods. View
us-gaap Operating Costs and Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. View
us-gaap Impaired Financing Receivable, Interest Income, Cash Basis Method Amount of interest income recognized on a cash-basis method of accounting that the financing receivables (with related allowance for credit losses and without a related allowance for credit losses) were impaired. View
us-gaap Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Amount of increase (decrease) in accrued expenses, and obligations classified as other. View
us-gaap Accounts Payable, Trade, Current Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals. View
us-gaap Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Amount after tax of income (loss) from continuing operations attributable to the parent. View
us-gaap Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method. View
us-gaap Investment Owned, Balance, Principal Amount For investments which are quantified by principal amount, the principle balance held at close of period. View
us-gaap Net Cash Provided by (Used in) Operating Activities, Continuing Operations Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Noncash or Part Noncash Acquisition, Payables Assumed "The amount of payables that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Proceeds from Debt, Net of Issuance Costs The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. View
us-gaap Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement. View
us-gaap Retained Earnings, Appropriated A segregation of retained earnings which is unavailable for dividend distribution. Includes also retained earnings appropriated for loss contingencies. View
us-gaap Revenue Recognition, Milestone Method, Revenue Recognized The amount of consideration recognized during the period for the milestone or milestones. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Rate of weighted-average expected volatility for award under share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted average price of options that were either forfeited or expired. View
us-gaap Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost The excess of the fair value of the modified award over the fair value of the award immediately before the modification. View
us-gaap Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate The risk-free interest rate assumption that is used in valuing a nonvested share or option award issued to other than an employee. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares Number of non-vested options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Number of non-vested options forfeited. View
us-gaap Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants Value of preferred stock and warrants for common stock issued. View
us-gaap Stock Issued The fair value of stock issued in noncash financing activities. View
us-gaap Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. View
us-gaap Assets, Fair Value Disclosure Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Common Stock, Capital Shares Reserved for Future Issuance Aggregate number of common shares reserved for future issuance. View
us-gaap Debt Instrument, Face Amount Face (par) amount of debt instrument at time of issuance. View
us-gaap Debt Instrument, Interest Rate, Effective Percentage Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. View
us-gaap Net Income (Loss) Allocated to General Partners Aggregate amount of net income allocated to general partners. View
us-gaap Payments of Financing Costs The cash outflow for loan and debt issuance costs. View
us-gaap Principal Amount Outstanding of Loans Held-in-portfolio This is the result of the principal amount outstanding of total loans managed or securitized less securitized loans and loans that are in the process of being securitized. View
us-gaap Research and Development Expense, Software (Excluding Acquired in Process Cost) Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed. View
us-gaap Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability. View
us-gaap Fair Value, Option, Changes in Fair Value, Gain (Loss) For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings. View
us-gaap Lease Incentive Receivable This item represents a receivable for an incentive or inducement contractually stipulated between parties to a lease whereby the lessor has committed to provide the entity (lessee) with a cash payment as inducement to enter the lease. View
us-gaap Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. View
us-gaap Purchase Obligation, to be Paid, Remainder of Fiscal Year Amount of purchase arrangement to be paid in remainder of current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. View
us-gaap Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Temporary Equity, Foreign Currency Translation Adjustments Adjustments to temporary equity resulting from foreign currency translation adjustments. View
us-gaap Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. View
us-gaap APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. View
us-gaap Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. View
us-gaap Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset Amount of beneficial interest received as consideration for transferring noncash financial asset. Includes, but is not limited to, trade receivable in securitization transaction. View
us-gaap Deferred Revenue, Current Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. View
us-gaap Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Employee-related Liabilities, Current Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Increase (Decrease) in Employee Related Liabilities The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. View
us-gaap Increase (Decrease) in Other Receivables Amount of increase (decrease) in receivables classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other. View
us-gaap Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year. View
us-gaap Lessee, Operating Lease, Liability, Undiscounted Excess Amount Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease. View
us-gaap Notes Receivable, Fair Value Disclosure Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date. View
us-gaap Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. View
us-gaap Proceeds from Issuance Initial Public Offering The cash inflow associated with the amount received from entity's first offering of stock to the public. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Short-term Lease Commitment, Amount Amount of short-term lease commitment. View
us-gaap Accounts Payable, Interest-bearing, Interest Rate Reflects the effective interest rate as of the balance sheet date on interest-bearing trade payables. View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Construction in Progress, Gross Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service. View
us-gaap Debt Conversion, Converted Instrument, Amount "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Deferred State and Local Income Tax Expense (Benefit) Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards. View
us-gaap Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile. View
us-gaap Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Operating Lease, Payments Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use. View
us-gaap Payments for Other Fees Amount of cash outflow for fees classified as other. View
us-gaap Short-term Bank Loans and Notes Payable Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer. View
us-gaap Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return. View
us-gaap Warrant, Exercise Price, Increase Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. View
us-gaap Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. View
us-gaap Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. View
us-gaap Other Assets Amount of assets classified as other. View
us-gaap Adjustments to Additional Paid in Capital, Other Amount of other increase (decrease) in additional paid in capital (APIC). View
us-gaap Compensated Absences Liability Amount of liability accrued for the employer's obligation related to an employee's right to receive compensation for future absences that have been earned by employee. View
us-gaap Contract with Customer, Liability, Current Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. View
us-gaap Conversion of Stock, Amount Issued "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Increase (Decrease) in Contract with Customer, Liability Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. View
us-gaap Long-term Investments The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle). View
us-gaap Sales Commissions and Fees Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Stock Issued During Period, Shares, Acquisitions Number of shares of stock issued during the period pursuant to acquisitions. View
us-gaap Stock Issued During Period, Shares, Restricted Stock Award, Gross Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. View
us-gaap Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants. View
us-gaap Revenue Not from Contract with Customer Amount of revenue that is not accounted for under Topic 606. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Surplus Notes Financial instruments issued by insurance entities (surplus notes) that are includable in surplus for statutory accounting purposes as prescribed or permitted by state laws and regulations that are liabilities of the issuer. View
us-gaap Tax Adjustments, Settlements, and Unusual Provisions Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement. View
us-gaap Temporary Equity, Carrying Amount, Attributable to Parent Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year One Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Inventory Write-down Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. View
us-gaap Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. View
us-gaap Increase (Decrease) in Deferred Revenue Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. View
us-gaap Noncash or Part Noncash Acquisition, Accounts Receivable Acquired "The amount of accounts receivable that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Payments for Repurchase of Warrants The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt. View
us-gaap Property, Plant and Equipment, Salvage Value, Percentage Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost. View
Chart of Accounts => Accounts
Name View
Accounts Payable, Current View
Accounts Payable View
Accrued Liabilities View
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax View
Additional Paid in Capital View
Share-based Payment Arrangement, Expense View
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount View
Assets View
Assets, Current View
Cash View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Debt Instrument, Convertible, Beneficial Conversion Feature View
Debt Instrument, Convertible, Conversion Price View
Debt Instrument, Fee Amount View
Deferred Federal Income Tax Expense (Benefit) View
Deferred Foreign Income Tax Expense (Benefit) View
Deferred Offering Costs View
Deferred Tax Assets, Goodwill and Intangible Assets View
Deferred Tax Assets, Gross View
Deferred Tax Assets, in Process Research and Development View
Deferred Tax Assets, Tax Credit Carryforwards, Research View
Deferred Tax Assets, Valuation Allowance View
Depreciation, Depletion and Amortization View
Dividends Payable, Current View
Dividends, Preferred Stock, Stock View
Due from Related Parties View
Earnings Per Share, Basic and Diluted View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent View
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent View
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount View
General and Administrative Expense View
Increase (Decrease) in Accounts Payable View
Increase (Decrease) in Prepaid Expense View
Interest Income (Expense), Net View
Operating Leases, Rent Expense View
Liabilities View
Liabilities and Equity View
Liabilities, Current View
Manufacturing Costs View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Investing Activities View
Net Cash Provided by (Used in) Operating Activities View
Net Income (Loss) Attributable to Parent View
Net Income (Loss) Attributable to Noncontrolling Interest View
Net Income (Loss) Available to Common Stockholders, Basic View
Nonoperating Income (Expense) View
Operating Expenses View
Operating Income (Loss) View
Operating Lease, Cost View
Operating Leases, Future Minimum Payments Due View
Operating Leases, Future Minimum Payments Due, Next Twelve Months View
Operating Leases, Future Minimum Payments, Due in Two Years View
Operating Loss Carryforwards View
Other Accrued Liabilities, Noncurrent View
Other Comprehensive Income (Loss), Tax View
Other Income View
Other Liabilities, Current View
Other Preferred Stock Dividends and Adjustments View
Other Research and Development Expense View
Payments of Stock Issuance Costs View
Payments to Acquire Property, Plant, and Equipment View
Preconfirmation, Cash and Cash Equivalents View
Preferred Stock, Dividend Rate, Percentage View
Preferred Stock Dividends, Income Statement Impact View
Preferred Stock, Par or Stated Value Per Share View
Preferred Stock, Shares Authorized View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Prepaid Expense and Other Assets View
Prepaid Expense and Other Assets, Current View
Proceeds from Issuance of Common Stock View
Proceeds from Issuance of Preferred Stock and Preference Stock View
Proceeds from Issuance of Private Placement View
Proceeds from Issuance of Warrants View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Property, Plant and Equipment, Net View
Research and Development Expense View
Research and Development Expense (Excluding Acquired in Process Cost) View
Research and Development in Process View
Restricted Cash View
Retained Earnings (Accumulated Deficit) View
Revenues View
Sale of Stock, Consideration Received on Transaction View
Sale of Stock, Number of Shares Issued in Transaction View
Sale of Stock, Price Per Share View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested View
Share Price View
Stockholders' Equity Attributable to Parent View
Stock Issued During Period, Shares, New Issues View
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Stock Issued During Period, Value, Issued for Services View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Other View
Surplus Notes View
Tax Adjustments, Settlements, and Unusual Provisions View
Temporary Equity, Carrying Amount, Attributable to Parent View
Temporary Equity, Liquidation Preference View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Weighted Average Number of Shares Outstanding, Basic View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Deferred Tax Assets, Operating Loss Carryforwards View
Increase (Decrease) in Accrued Salaries View
Capital Expenditures Incurred but Not yet Paid View
Earnings Per Share, Basic View
Other Expenses View
Other General and Administrative Expense View
Other Receivables View
Percentage of Weighted Average Cost Inventory View
Weighted Average Number of Shares Outstanding, Diluted View
Earnings Per Share, Diluted View
368194 View
Lease, Cost View
Lessee, Operating Lease, Liability, to be Paid View
Lessee, Operating Lease, Liability, to be Paid, Year One View
Lessee, Operating Lease, Liability, to be Paid, Year Four View
Lessee, Operating Lease, Liability, to be Paid, Year Three View
Lessee, Operating Lease, Liability, to be Paid, Year Two View
Long-term Debt and Lease Obligation, Current View
Operating Lease, Lease Income, Lease Payments View
Operating Lease, Liability View
Operating Lease, Liability, Current View
Operating Lease, Liability, Noncurrent View
Operating Lease, Right-of-Use Asset View
Operating Lease, Right-of-Use Asset, Amortization Expense View
Operating Lease, Weighted Average Discount Rate, Percent View
Other Assets, Noncurrent View
Receivable with Imputed Interest, Net Amount View
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period View
Stock Issued During Period, Value, Stock Options Exercised View
Weighted Average Number Diluted Shares Outstanding Adjustment View
Derivative, Gain (Loss) on Derivative, Net View
Increase (Decrease) in Prepaid Expenses, Other View
Operating Costs and Expenses View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value View
Accounts Payable, Trade, Current View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals View
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent View
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants View
Investment Owned, Balance, Principal Amount View
Net Cash Provided by (Used in) Operating Activities, Continuing Operations View
Noncash or Part Noncash Acquisition, Payables Assumed View
Proceeds from Debt, Net of Issuance Costs View
Proceeds from Stock Options Exercised View
Retained Earnings, Appropriated View
Revenue Recognition, Milestone Method, Revenue Recognized View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price View
Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost View
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares View
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants View
Stock Issued View
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs View
Assets, Fair Value Disclosure View
Common Stock, Capital Shares Reserved for Future Issuance View
Debt Instrument, Face Amount View
Debt Instrument, Interest Rate, Effective Percentage View
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed View
Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs View
Impaired Financing Receivable, Interest Income, Cash Basis Method View
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities View
Inventory Write-down View
Net Income (Loss) Allocated to General Partners View
Payments of Financing Costs View
Principal Amount Outstanding of Loans Held-in-portfolio View
Research and Development Expense, Software (Excluding Acquired in Process Cost) View
Accumulated Other Comprehensive Income (Loss), Net of Tax View
Fair Value Adjustment of Warrants View
Fair Value, Option, Changes in Fair Value, Gain (Loss) View
Lease Incentive Receivable View
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax View
Purchase Obligation, to be Paid, Remainder of Fiscal Year View
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture View
Temporary Equity, Foreign Currency Translation Adjustments View
Additional Paid in Capital, Common Stock View
Comprehensive Income (Loss), Net of Tax, Attributable to Parent View
Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset View
Deferred Revenue, Current View
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Employee-related Liabilities, Current View
Increase (Decrease) in Deferred Revenue View
Increase (Decrease) in Employee Related Liabilities View
Increase (Decrease) in Other Receivables View
Increase (Decrease) in Prepaid Expense and Other Assets View
Investment Income, Interest View
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year View
Lessee, Operating Lease, Liability, Undiscounted Excess Amount View
Noncash or Part Noncash Acquisition, Accounts Receivable Acquired View
Notes Receivable, Fair Value Disclosure View
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax View
Proceeds from Issuance Initial Public Offering View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Short-term Lease Commitment, Amount View
Accounts Payable, Interest-bearing, Interest Rate View
Accrued Liabilities, Current View
Construction in Progress, Gross View
Debt Conversion, Converted Instrument, Amount View
Deferred State and Local Income Tax Expense (Benefit) View
Deferred Tax Assets, Tax Credit Carryforwards View
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent View
Increase (Decrease) in Accrued Liabilities View
Interest Expense View
Operating Lease, Payments View
Payments for Other Fees View
Payments for Repurchase of Warrants View
Property, Plant and Equipment, Salvage Value, Percentage View
Short-term Bank Loans and Notes Payable View
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued View
Warrant, Exercise Price, Increase View
Class of Warrant or Right, Number of Securities Called by Warrants or Rights View
Interest Paid, Excluding Capitalized Interest, Operating Activities View
Other Assets View
Adjustments to Additional Paid in Capital, Other View
Compensated Absences Liability View
Contract with Customer, Liability, Current View
Conversion of Stock, Amount Issued View
Increase (Decrease) in Contract with Customer, Liability View
Long-term Investments View
Sales Commissions and Fees View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value View
Stock Issued During Period, Shares, Acquisitions View
Stock Issued During Period, Shares, Restricted Stock Award, Gross View
Proceeds from Warrant Exercises View
Revenue Not from Contract with Customer View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price View
Payment of Financing and Stock Issuance Costs View
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings View
APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period View